Plymouth Meeting, PA, December 1, 2025
Harmony Biosciences Holdings, Inc. is set to present its strategic vision and pipeline developments at three major healthcare conferences in Miami and New York. These engagements aim to foster communication with investors and update on innovative therapies for rare neurological diseases. The participation underscores the company’s dedication to transparency in its ongoing initiatives in biotechnology.
Plymouth Meeting, PA – Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), an innovative player in the pharmaceutical sector, is preparing to showcase its strategic vision and pipeline developments at three key healthcare conferences. These engagements are designed to foster communication with potential investors and provide updates on the company’s future initiatives.
The company will participate in the following prominent events:
- Citi’s 2025 Global Healthcare Conference
Location: Miami, FL
Date: Tuesday, December 2, 2025 - 8th Annual Evercore Healthcare Conference
Location: Miami, FL
Fireside Chat: Tuesday, December 2, 2025, at 2:35 p.m. ET - Piper Sandler 37th Annual Healthcare Conference
Location: New York, NY
Fireside Chat: Wednesday, December 3, 2025, at 10:30 a.m. ET
Investors and interested parties can access webcasts of the fireside chats through Harmony Biosciences’ investor relations website at https://ir.harmonybiosciences.com/. These conferences represent an essential opportunity for Harmony Biosciences to elaborate on its ongoing initiatives and future plans in the biotechnology field.
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that focuses on developing and commercializing innovative therapies for patients suffering from rare neurological diseases with unmet medical needs. Established by Paragon Biosciences, LLC in 2017, and headquartered in Plymouth Meeting, PA, the organization is committed to advancing therapeutic innovations while fostering a culture centered around empathy and scientific rigor.
The upcoming conferences reflect Harmony’s dedication to transparency and its proactive approach to investor engagement. As the company continues to grow, its participation in prominent industry events like these underscores the resilience of the pharmaceutical sector in navigating regulatory landscapes while aiming to introduce life-changing therapies to the market.
Harmony Biosciences’ recent activities highlight its focus on innovation. Notably, the company has announced positive results from pivotal studies on its gastro-resistant formulation of pitolisant and initiated a first-in-human study for a potential best-in-class orexin 2 receptor agonist aimed at treating central disorders of hypersomnolence. These developments are promising indicators of the company’s trajectory toward expanding its therapeutic offerings.
The commitment of Harmony Biosciences to high-quality research and development, coupled with its strategic governance, positions the company as a contributing force in Philadelphia’s economic landscape, emphasizing the city’s growing role in the life sciences sector.
To summarize, Harmony Biosciences is showcasing its innovations and addressing the needs of patients through its participation in significant healthcare conferences. The organization’s strategy and pipeline developments will be critical in delineating its path toward broader success and community impact.
Key Takeaways
– Harmony Biosciences will be presenting at three key healthcare conferences in December 2025.
– The company is committed to developing therapies for rare neurological diseases.
– Recent positive study results suggest promising advancements in their pipeline.
Call to Action
Support local innovation and stay informed about the vibrant community of small businesses and entrepreneurial ventures in Philadelphia as we continue to witness substantial developments in our economic landscape.
FAQs
What are the upcoming investor conferences that Harmony Biosciences will participate in?
Harmony Biosciences will participate in the following investor conferences:
- Citi’s 2025 Global Healthcare Conference
Location: Miami, FL
Date: Tuesday, December 2, 2025 - 8th Annual Evercore Healthcare Conference
Location: Miami, FL
Fireside Chat: Tuesday, December 2, 2025, at 2:35 p.m. ET - Piper Sandler 37th Annual Healthcare Conference
Location: New York, NY
Fireside Chat: Wednesday, December 3, 2025, at 10:30 a.m. ET
Where can I access the webcasts of the fireside chats?
The webcasts of the fireside chats will be available on Harmony Biosciences’ investor relations website at https://ir.harmonybiosciences.com/.
What is the focus of Harmony Biosciences as a pharmaceutical company?
Harmony Biosciences is dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. The company focuses on advancing therapeutic innovations and fostering a culture that prioritizes empathy and scientific rigor.
How can I contact Harmony Biosciences for investor relations or media inquiries?
For investor relations, contact Matthew Beck at 917-415-1750 or [email protected]. For media inquiries, contact Cate McCanless at 202-641-6086 or [email protected].
Where is Harmony Biosciences headquartered?
Harmony Biosciences is headquartered in Plymouth Meeting, PA.
What is the stock ticker symbol for Harmony Biosciences?
The stock ticker symbol for Harmony Biosciences is HRMY.
What is the stock price of Harmony Biosciences as of December 1, 2025?
The stock price of Harmony Biosciences is $35.84 USD, with a change of $0.55 (1.56%) from the previous close. The intraday high is $36.00 USD, and the intraday low is $35.30 USD. The latest open price was $35.60 USD, and the intraday volume is 151,595. The latest trade time is Monday, December 1, 2025, at 4:24:10 PM UTC.
| Feature | Details |
|---|---|
| Company Name | Harmony Biosciences Holdings, Inc. |
| Stock Symbol | HRMY |
| Headquarters | Plymouth Meeting, PA |
| Conference Dates | December 2-3, 2025 |
| Focus Area | Innovative therapies for rare neurological diseases |
| Investment Opportunities | Engagement with investors through conferences and webcasts |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: STAFF HERE PHILADELPHIA WRITER
The PHILADELPHIA STAFF WRITER represents the experienced team at HEREPhiladelphia.com, your go-to source for actionable local news and information in Philadelphia, Philadelphia County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Mummers Parade, Philadelphia Flower Show, and Thanksgiving Day Parade. Our coverage extends to key organizations like the Greater Philadelphia Chamber of Commerce and United Way of Greater Philadelphia, plus leading businesses in telecommunications, food services, and healthcare that power the local economy such as Comcast, Aramark, and Children's Hospital of Philadelphia. As part of the broader HERE network, we provide comprehensive, credible insights into Pennsylvania's dynamic landscape.
